Newsletter summer 2020

Toxys Newsletter March 2020
View this email in your browser
Toxys logo
Get to know our developmental toxicity in vitro assay, ReproTracker in a webinar
Recently, we launched our novel developmental toxicity in vitro assay, ReproTracker. ReproTracker is a human induced pluripotent stem cell-based assay for developmental and reproductive toxicology screening. The assay is able to identify compounds that interfere with early embryonic development. introduce webinar

insert picture, click to sign up for webinar?
To get a glimpse into our previous webinars, check out our recorded webinars at the ToxTracker Academy here.
Toxys launches its new in vitro Genotoxicity assay TubulinTracker

The TubulinTracker assay is a state-of-the-art stem cell-based reporter assay that rapidly and reliably discriminates between tubulin stabilisers and destabilisers affecting cell cycle dynamics. TubulinTracker is  flow cytometry-based, identifying aneugenic properties of compounds that are associated with genotoxicity. TubulinTracker displays high sensitivity and specificity and provides mechanistic insight into the Mode-of-Action (MOA) for microtubule disruption. The mechanistic insight into the MOA provided by this assay is important for hazard identification and as part of weight of evidence approaches. TubulinTracker can either be used as a follow up to our ToxTracker ACE or as a stand alone assay to determine the MOA of tubulin poisons. Click here to find out more about this novel assay.

News in short

A new state-of-the-art laboratory
Toxys is growing and rapidly expanding its in vitro chemical safety testing services. Recently, Toxys signed an agreement with BioPartner Leiden for its new laboratory facilities. In spring 2021, Toxys will relocate to the new BioPartner V laboratory building at the Leiden Bio Science Park. 

BioPartner is currently building a state-of-the-art laboratory facility with flexible labs and offices. The innovative building is constructed from recycled materials and uses natural, eco-friendly materials to provide a sustainable and inspiring working environment. The building is the perfect location for Toxys to expand its modern laboratory facilities, ready for further expansion of its specialized toxicological research services and allowing further growth of the company.

insert three pix

Welcoming our new colleagues!
Not only are we expanding our services, we are also growing as a team. Recently, we welcomed our Marketing Manager, Pereni, and Title, Hannah, to accelerate our growth and to expand our reach. 

name, title (hyperlink to linkedin?) 

New Publications


COVID-19 contingency planning and continuity of Toxys services

Toxys has been monitoring the global corona virus outbreak since the beginning of this year and is updating business continuity plans daily. We want to assure you that we remain dedicated to provide high quality services to our clients while also protecting the health of our employees.

Toxys closely follows the instructions from the Dutch national institute for public health. We recognise that the situation is evolving rapidly and we have taken proactive measures to mitigate  risk while maintaining business continuity.

  • The Toxys laboratories remain fully operational and continue to provide high quality services
  • The timelines for ToxTracker and other services have not changed
  • Toxys has sufficient certified lab personnel to ensure the continuity of all service activities
  • Our scientists and technical  experts remain available to support your projects

Despite the unprecedented circumstances, we remain committed to support our clients to develop better and safe products. Please contact us for more information.

Get in contact
We will attend and give presentations at several conferences. We are more than happy to meet alongside any of these meetings. If you are interested to learn more about our unique assays we could also schedule a TC to tell you more about our technologies and services.

Meetings we will attend
Given the Covid-19 situation many conferences have been cancelled. Instead of joining conferences we are open to scheduling TC's.

Please contact us if there are any questions: 

Paula van Rossum                                          Ruairi Mac Siomoin
Director BD & Sales                                        Japan liaison (Eaolas Biosciences)                         
+31 - 71 - 3322470                                          +81-47-308-2204

Learn more about our unique services
Copyright © 2019, All rights reserved.

Our mailing address is:

Please visit our website for more information on our products and services and our privacy policy:

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.